{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T00:28:31Z","timestamp":1771460911808,"version":"3.50.1"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2019,1,17]],"date-time":"2019-01-17T00:00:00Z","timestamp":1547683200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hautarzt"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1007\/s00105-018-4346-8","type":"journal-article","created":{"date-parts":[[2019,1,17]],"date-time":"2019-01-17T12:02:21Z","timestamp":1547726541000},"page":"101-106","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Altersspezifische Besonderheiten bei der Versorgung von Angio\u00f6dempatienten","Age-specific aspects in the treatment of angioedema patients"],"prefix":"10.1007","volume":"70","author":[{"given":"P.","family":"Staubach","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,1,17]]},"reference":[{"issue":"5","key":"4346_CR1","first-page":"273","volume":"75","author":"E Malbran","year":"2015","unstructured":"Malbran E, Fernandez Romero D, Juri MC et\u00a0al (2015) Epidemiology of angioedema without wheals in an allergy and immunology center. Medicina (B Aires) 75(5):273\u2013276","journal-title":"Medicina (B Aires)"},{"issue":"1","key":"4346_CR2","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1111\/pai.12146","volume":"25","author":"I Br\u00fcske","year":"2014","unstructured":"Br\u00fcske I, Standl M, Weidinger S et\u00a0al (2014) Epidemiology of urticaria in infants and young children in Germany\u2014results from the German LISAplus and GINIplus Birth Cohort Studies. Pediatr Allergy Immunol 25(1):36\u201342","journal-title":"Pediatr Allergy Immunol"},{"issue":"3","key":"4346_CR3","doi-asserted-by":"publisher","first-page":"268","DOI":"10.2340\/00015555-1511","volume":"93","author":"C Caffarelli","year":"2013","unstructured":"Caffarelli C, Cuomo B, Cardinale F et\u00a0al (2013) Aetiological factors associated with chronic urticaria in children: a\u00a0systematic review. Acta Derm Venereol 93(3):268\u2013272","journal-title":"Acta Derm Venereol"},{"issue":"5","key":"4346_CR4","first-page":"e20160575","volume":"138","author":"MM Frank","year":"2016","unstructured":"Frank MM, Zuraw B, Banerji A (2016) Management of children with hereditary Angioedema Due to C1 inhibitor deficiency. US hereditary Angioedema association medical advisory board. Pediatr Electron Pages 138(5):e20160575","journal-title":"Pediatr Electron Pages"},{"issue":"8","key":"4346_CR5","first-page":"1575","volume":"73","author":"M Maurer","year":"2018","unstructured":"Maurer M, Magerl M, Ansotegui I et\u00a0al (2018) The international WAO\/EAACI guideline for the management of hereditary angioedema \u2013 the 2017 revision and update. Arerugi 73(8):1575\u20131596","journal-title":"Arerugi"},{"issue":"6","key":"4346_CR6","doi-asserted-by":"publisher","first-page":"425","DOI":"10.2500\/aap.2015.36.3911","volume":"36","author":"JL Kulen","year":"2015","unstructured":"Kulen JL, Banerji A (2015) Hereditary angioedema: special consideration in children, women of childbearing age, and the elderly. Allergy Asthma Proc 36(6):425\u2013432","journal-title":"Allergy Asthma Proc"},{"issue":"5","key":"4346_CR7","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1016\/j.jaip.2016.12.032","volume":"5","author":"A Zanichelli","year":"2017","unstructured":"Zanichelli A, Azin GM, Wu MA (2017) Diagnosis, course, and management of Angioedema in patients with acquired C1-inhibitor deficiency. J\u00a0Allergy Clin Immunol Pract 5(5):1307\u20131313","journal-title":"J Allergy Clin Immunol Pract"},{"key":"4346_CR8","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/s13671-015-0104-7","volume":"4","author":"P Staubach","year":"2015","unstructured":"Staubach P, Gilfert T (2015) Paediatric urticaria. Curr Derm Rep 4:83\u201389","journal-title":"Curr Derm Rep"},{"issue":"7","key":"4346_CR9","first-page":"1393","volume":"73","author":"T Zuberbier","year":"2018","unstructured":"Zuberbier T, Aberer W, Asero R et\u00a0al (2018) The EAACI\/GA(2) LEN\/EDF\/WAO Guideline for the definition, classification, diagnosis, and management of urticaria: the 2016 revision and update. Arerugi 73(7):1393\u20131141","journal-title":"Arerugi"},{"issue":"4","key":"4346_CR10","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1007\/s00105-004-0694-7","volume":"55","author":"D Wieczorek","year":"2004","unstructured":"Wieczorek D, Raap U, Liekenbr\u00f6cker T (2004) Chronic urticaria in childhood. Hautarzt 55(4):357\u2013360","journal-title":"Hautarzt"},{"key":"4346_CR11","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1007\/s00105-017-3985-5","volume":"68","author":"H Ott","year":"2017","unstructured":"Ott H (2017) Chronic urticaria in childhood: Rational diagnostics and treatment. Hautarzt 68:571\u2013582","journal-title":"Hautarzt"},{"issue":"2","key":"4346_CR12","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1111\/all.13001","volume":"72","author":"H Farkas","year":"2017","unstructured":"Farkas H, Martinez-Saguer I, Bork K (2017) et\u00a0al. International consensus on the diagnosis and management of pediatric patients with hereditary angioedema with C1 inhibitor deficiency. Allergy 72(2):300\u2013313","journal-title":"Allergy"},{"issue":"4","key":"4346_CR13","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1111\/j.1398-9995.2009.02325.x","volume":"65","author":"MK Church","year":"2010","unstructured":"Church MK, Maurer M, Simons FER et al (2010) Risk of first-generation H(1)-antihistamines: a\u00a0GA(2)LEN position paper. Allergy 65(4):459\u2013466","journal-title":"Allergy"},{"key":"4346_CR14","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1111\/all.12870","volume":"71","author":"P Staubach","year":"2016","unstructured":"Staubach P, Metz M, Chapman-Rothe N et al (2016) Effect of omalizumab on angioedema in H1-antihistamine-resistant chronic spontaneous urticaria patients: results from X\u2011ACT, a\u00a0randomized controlled trial. Allergy 71:1135\u20131144","journal-title":"Allergy"},{"issue":"6","key":"4346_CR15","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1007\/s40272-014-0107-z","volume":"16","author":"A Licari","year":"2014","unstructured":"Licari A, Marseglia A, Caimmi S et\u00a0al (2014) Omalizumab in children. Paediatr Drugs 16(6):491\u2013502","journal-title":"Paediatr Drugs"},{"issue":"4","key":"4346_CR16","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1016\/j.jaip.2014.04.011","volume":"2","author":"L Neverman","year":"2014","unstructured":"Neverman L, Weinberger M (2014) Treatment of chronic urticaria in children with antihistamines and cyclosporine. J\u00a0Allergy Clin Immunol Pract 2(4):434\u2013438","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"2","key":"4346_CR17","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1007\/s40272-017-0273-x","volume":"20","author":"H Farkas","year":"2017","unstructured":"Farkas H (2017) Pharmacological management of hereditary Angioedema with C1-inhibitor deficiency in pediatric patients. Pediatr Drugs 20(2):135\u2013151","journal-title":"Pediatr Drugs"},{"issue":"12","key":"4346_CR18","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1056\/NEJMoa1613627","volume":"376","author":"H Longhurst","year":"2017","unstructured":"Longhurst H, Cicardi M, Craig T et\u00a0al (2017) Prevention of hereditary Angioedema attacks with a\u00a0subcutaneous C1 inhibitor. N\u00a0Engl J Med 376(12):1131\u20131140","journal-title":"N Engl J Med"},{"issue":"6","key":"4346_CR19","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1080\/1744666X.2018.1476851","volume":"14","author":"H Farkas","year":"2018","unstructured":"Farkas H, K\u0151halmi KV (2018) Icatibant for the treatment of hereditary angioedema with C1-inhibitor deficiency in adolescents and in children aged over 2 years. Expert Rev Clin Immunol 14(6):447\u2013460","journal-title":"Expert Rev Clin Immunol"},{"issue":"6","key":"4346_CR20","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.1016\/j.jaip.2017.04.010","volume":"5","author":"H Farkas","year":"2017","unstructured":"Farkas H, Reshef A, Aberer W et\u00a0al (2017) Treatment Effect and Safety of Icatibant in Pediatric Patients with Hereditary Angioedema. J\u00a0Allergy Clin Immunol Pract 5(6):1671\u20131678","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"20","key":"4346_CR21","doi-asserted-by":"publisher","first-page":"2108","DOI":"10.1001\/jama.2018.16773","volume":"320","author":"A Banerji","year":"2018","unstructured":"Banerji A, Riedl MA, Bernstein JA et\u00a0al (2018) Effect of Lanadelumab compared with placebo on prevention of hereditary angioedema attacks. A randomized clinical trial. JAMA 320(20):2108\u20132121","journal-title":"JAMA"},{"key":"4346_CR22","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1007\/s00105-013-2569-2","volume":"64","author":"P Staubach","year":"2013","unstructured":"Staubach P, Groffik A (2013) Useful tools for documenting urticaria. Hautarzt 64:650\u2013655","journal-title":"Hautarzt"}],"container-title":["Der Hautarzt"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00105-018-4346-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-018-4346-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-018-4346-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,1,17]],"date-time":"2020-01-17T00:04:10Z","timestamp":1579219450000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00105-018-4346-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,17]]},"references-count":22,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,2]]}},"alternative-id":["4346"],"URL":"https:\/\/doi.org\/10.1007\/s00105-018-4346-8","relation":{},"ISSN":["0017-8470","1432-1173"],"issn-type":[{"value":"0017-8470","type":"print"},{"value":"1432-1173","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,17]]},"assertion":[{"value":"17 January 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"P.\u00a0Staubach erhielt Verg\u00fctung von T\u00e4tigkeiten im Rahmen klinischer Studien, Referenten- und Beratert\u00e4tigkeiten sowie Reisekosten\u00fcbernahme von Almirall, CSL Behring, Novartis, Octapharma, Pfleger, Shire, Sobi Pharma, Viropharma.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"Dieser Beitrag beinhaltet keine vom Autor durchgef\u00fchrten Studien an Menschen oder Tieren. F\u00fcr Bildmaterial oder anderweitige Angaben innerhalb des Manuskripts, \u00fcber die Patienten zu identifizieren sind, liegt von ihnen und\/oder ihren gesetzlichen Vertretern eine schriftliche Einwilligung vor.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}